Skip to main content

Table 1 Characteristics of participants (n (%) and mean ± SD

From: Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation

  Completed (n = 107) On treatment (n = 55) Discontinued (n = 45)
Female 53 (50%) 32 (58%) 20 (44%)
Age (years) 41 ± 11 37 ± 12 35 ± 9
Other allergies 77 (73%) 38 (72%) 30 (68%)
Asthma 47 (44%) 28 (53%) 20 (44%)
Year treatment starteda
 2016 20 (39%) 9 (23%)
 2015 18 (35%) 5 (13%)
 2014 8 (8%) 13 (25%) 6 (15%)
 2013 29 (30%)   4 (10%)
 2012 14 (14%)   7 (18%)
 2011 12 (12%)   3 (8%)
 2010 7 (7%)   2 (5%)
 2009 12 (12%)   1 (3%)
 2008 8 (8%)   0
 2007
 2006 7 (7%)   2 (5%)
  1. aInformation missing for 20 patients